Melatonin in Relapsing-Remitting Multiple Sclerosis Patients
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether melatonin is effective in the treatment of
relapsing-remitting multiple sclerosis patients as a supplement to the main disease-modifying
drugs.